This is the authors' abstract. We don't add key points for this paper.
Chronic hepatitis B virus (HBV) infection is one of the major causes of hepatocellular carcinoma (HCC), and the HBV pre-S gene plays a critical role in the molecular pathogenesis of HBV-related HCC.We have investigated whether there are particular HBV pre-S gene mutations associated with HCC in patients from southern China.The HBV pre-S gene was examined in 100 paraffin-embedded tumor tissue and 100 paraffin-embedded paracancerous tissue samples from patients with HCC by nested polymerase chain reaction (PCR).The HBV pre-S genes with potentially important mutations from tumor tissue samples were sequenced and aligned with the published HBV pre-S gene sequence.Twelve patients (12.0%) had pre-S mutations; six had a pre-S1 deletion, one patient had a pre-S2_ deletion, five patients had both a pre-S deletion, and a pre-S2 mutation.Among them, two patients contained pre-S1 insertion and two patients contained pre-S1 start codon mutation.Two patients (2.0%) of hepatocellular carcinoma paracancerous tissue had pre-S mutation and two patients had pre-S1 + pre-S2 deletion.The pre-S sequence of HBV contained stop codon in four patients of HCC, leading to truncated pre-S protein and changed protein structure.These results suggest that HBV pre-S gene deletion mutation and insertion mutation in HCC tissues and paracancerous tissues lead to truncated HBV pre-S protein or protein changes, which may be related to the occurrence of hepatocellular carcinoma.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ping An Zhu (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: